Viewing Study NCT02836795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:42 PM
Ignite Modification Date: 2026-02-08 @ 5:44 PM
Study NCT ID: NCT02836795
Status: COMPLETED
Last Update Posted: 2025-06-08
First Post: 2016-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid Tumors
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Urological Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anti-PD-1 monoclonal antibody View
None advanced solid tumors View
None safety View